The evidence supports this nomogram as a potential preoperative risk-stratification tool; it may, by inference, help select patients for intensified evaluation or treatment planning, but the record does not show that its use changes therapy, survival, toxicity, or other clinical outcomes.

The reported evidence supports including tuberculosis in the differential diagnosis of pediatric pulmonary masses in endemic or resource-limited settings; it is reasonable but unproven to infer that earlier microbiologic and clinicoradiologic evaluation could prevent diagnostic delay, inappropriate cancer-directed procedures, and delayed antituberculous treatment.

The record supports multidisciplinary, risk-stratified management as observed clinical practice; it does not demonstrate that any particular treatment strategy improves outcomes, although the cohort could generate hypotheses about care patterns in this population.

The evidence supports extrathyroidal extension as a potential clinicopathologic risk marker; it may help select patients for closer postoperative surveillance, but improved outcomes, treatment selection, and the optimal surveillance strategy were not tested.

The record provides low-level human evidence that TNF inhibition may control refractory JIA in some children with DiGeorge syndrome; it is only an inference that this represents a broadly effective or acceptably safe strategy because the primary evidence is a single case and the review supplies limited response and safety detail.

The paper states that identifying renal lesions by biopsy can guide oncologic therapy and help prevent further renal decline; it is reasonable to infer that better biopsy selection and interpretation could reduce inappropriate treatment changes or nephrotoxicity, but the supplied record provides no comparative or outcome evidence supporting this hypothesis.

The evidence identifies caregiver communication, comfort, safety, and concern-reporting as potential quality-improvement targets; it is reasonable—but not demonstrated by this study—to hypothesize that PPEQ-guided interventions could improve care experiences, safety, or treatment delivery.

The reported case provides evidence that ABVD administration during later pregnancy can coincide with favorable short-term maternal and neonatal outcomes under multidisciplinary monitoring; it only supports the inference—not proof—that this approach may be feasible for selected pregnant patients with Hodgkin lymphoma.

The reported case supports prompt neurosurgical evacuation for symptomatic subdural hematomas with mass effect; it only suggests, without establishing, that serial head-circumference assessment and timely neuroimaging might facilitate earlier detection in selected young children undergoing CNS-tumor treatment.

The reported outcome provides limited evidence that surgery followed by platinum-based combination chemotherapy can achieve durable disease control in this rare presentation; it is only an inference—not established by this single case—that this approach is broadly effective or optimal for neonatal intra-abdominal mixed germ cell tumours.

The evidence shows that host genetic background and exposure dose modify neonatal gammaherpesvirus latency and B-cell responses in mice; it can only be inferred—not established—that identifying the responsible host pathways might reveal targets for preventing or limiting chronic infection and subsequent virus-associated malignancy risk.

The reported evidence supports CT-guided recognition followed by surgical excision in this individual case; it suggests—but does not establish—that earlier CT imaging in children with persistent nocturnal, salicylate-responsive wrist pain and disproportionate MRI edema could reduce diagnostic delay and unnecessary infection-directed care.